Chiimatherapeutics
Founded 2021 · 2 employees on LinkedIn · 1 known investors
Find your way into Chiimatherapeutics
Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.
Investors · 1
Competitors · 2
by search overlap
Kymera Therapeutics3 shared keywordsKymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
Kimia3 shared keywordsKimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries. It focuses on improving outcomes for patients.
Companies competing with Chiimatherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Chiimatherapeutics do?
- Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.
- Who are Chiimatherapeutics's investors?
- Chiimatherapeutics's investors include The Innovation Space.